Literature DB >> 10027555

Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population.

H Toji1, H Maruyama, K Sasaki, S Nakamura, H Kawakami.   

Abstract

A recent observation has shown that a common polymorphism (-491 A) in the promoter of apolipoprotein E (APOE) was associated with an increased risk for Alzheimer's disease (AD) in European decent. Moreover, the promoter with -491 A showed higher transcriptional activity than that with -491 T. To investigate the further contribution of the polymorphism to the etiology of sporadic AD, we evaluated associations between Japanese AD and -491 A/T polymorphism of APOE. There was no significant difference between these cases and controls. The percentage of the homozygote of -491 A allele (AA) among the Japanese control population was significantly higher than that among the Spanish control population. The APOE promoter genotype frequencies may be influenced by the ethnic background. Our study failed to confirm any relationship between -491 A/T polymorphism and AD. Thus, we conclude that the APOE promoter polymorphism does not represent an additional risk factor for AD in Japanese populations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027555     DOI: 10.1016/s0304-3940(98)00855-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.

Authors:  Anna Juhász; András Palotás; Zoltán Janka; Agnes Rimanóczy; Miklós Palotás; Nikoletta Bódi; Krisztina Boda; Marianna Zana; Gábor Vincze; János Kálmán
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

2.  What Psychiatrists Should Know about Genes and Alzheimer's Disease.

Authors:  Edmund Howe
Journal:  Psychiatry (Edgmont)       Date:  2010-10

3.  Association between Alzheimer disease and the -491T allele of regulatory region polymorphism of Apolipoprotein E in a Tunisian population.

Authors:  Afef Achouri-Rassas; Sondes Hadj Fredj; Hela Mrabet Khiari; Amina Bibi; Hajer Siala; Amel Mrabet; Taieb Messaoud
Journal:  Neurochem Res       Date:  2013-12-11       Impact factor: 3.996

4.  The complex interaction between APOE promoter and AD: an Italian case-control study.

Authors:  Alessandra Bizzarro; Davide Seripa; Adele Acciarri; Maria Giovanna Matera; Alberto Pilotto; Francesco Danilo Tiziano; Christina Brahe; Carlo Masullo
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

5.  Late onset Alzheimer's disease and apolipoprotein association in the Irish population: relative risk and attributable fraction.

Authors:  Z Hawi; K Sheehan; A Lynch; I Evans; N Lowe; B Lawlor; M Gill
Journal:  Ir J Med Sci       Date:  2003 Apr-Jun       Impact factor: 1.568

6.  Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions.

Authors:  Bryan Maloney; Yuan-Wen Ge; Ronald C Petersen; John Hardy; Jack T Rogers; Jordi Pérez-Tur; Debomoy K Lahiri
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

7.  Genetic studies in Alzheimer's disease.

Authors:  Ya-Ping Tang; Elliot S Gershon
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

8.  Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer's disease: A meta-analysis.

Authors:  Hanyan Xiao; Yifeng Gao; Lei Liu; Yan Li
Journal:  EXCLI J       Date:  2017-06-20       Impact factor: 4.068

9.  APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer's Disease Risk in a Multiracial Sample.

Authors:  Kyu Yeong Choi; Jang Jae Lee; Tamil Iniyan Gunasekaran; Sarang Kang; Wooje Lee; Jangho Jeong; Ho Jae Lim; Xiaoling Zhang; Congcong Zhu; So-Yoon Won; Yu Yong Choi; Eun Hyun Seo; Seok Cheol Lee; Jungsoo Gim; Ji Yeon Chung; Ari Chong; Min Soo Byun; Sujin Seo; Pan-Woo Ko; Ji-Won Han; Catriona McLean; John Farrell; Kathryn L Lunetta; Akinori Miyashita; Norikazu Hara; Sungho Won; Seong-Min Choi; Jung-Min Ha; Jee Hyang Jeong; Ryozo Kuwano; Min Kyung Song; Seong Soo A An; Young Min Lee; Kyung Won Park; Ho-Won Lee; Seong Hye Choi; Sangmyung Rhee; Woo Keun Song; Jung Sup Lee; Richard Mayeux; Jonathan L Haines; Margaret A Pericak-Vance; I L Han Choo; Kwangsik Nho; Ki-Woong Kim; Dong Young Lee; SangYun Kim; Byeong C Kim; Hoowon Kim; Gyungah R Jun; Gerard D Schellenberg; Takeshi Ikeuchi; Lindsay A Farrer; Kun Ho Lee; Alzheimer's Disease Neuroimaging Initative
Journal:  J Clin Med       Date:  2019-08-16       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.